# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA708880 | F | Inhibition of LX-1 human lung carcinoma proliferation | Homo sapiens | 2 | ALA1135763 | cell-based format | Scientific Literature | |
2. | ALA1019948 | F | Cytotoxicity against human LX1 cells after 72 hrs by MTS method | Homo sapiens | 4 | ALA1159312 | cell-based format | Scientific Literature | |
3. | ALA1019957 | F | Cytotoxicity against human LX1 cells after 48 hrs by microplate assay | Homo sapiens | 6 | ALA1159313 | cell-based format | Scientific Literature | |
4. | ALA1001026 | F | Cytotoxicity against human LX1 cells | Homo sapiens | 1 | ALA1148901 | cell-based format | Scientific Literature | |
5. | ALA1035195 | F | In vivo antitumor activity against human LX1 cells at 2400 mg/kg administered on day 1, 5 and 9 relative to control | Homo sapiens | 1 | ALA1151613 | organism-based format | Scientific Literature | |
6. | ALA1033350 | F | In vivo antitumor activity against human LX1 cells at 1200 mg/kg administered on day 1, 5 and 9 relative to control | Homo sapiens | 1 | ALA1151613 | organism-based format | Scientific Literature | |
7. | ALA1033351 | F | In vivo antitumor activity against human LX1 cells at 600 mg/kg administered on day 1, 5 and 9 relative to control | Homo sapiens | 1 | ALA1151613 | organism-based format | Scientific Literature | |
8. | ALA1033352 | F | In vivo antitumor activity against human LX1 cells at 300 mg/kg administered on day 1, 5 and 9 relative to control | Homo sapiens | 1 | ALA1151613 | organism-based format | Scientific Literature |